Table 1.
Pharmacologic interventions | |||
---|---|---|---|
Lipid lowering medications | Blood pressure lowering medications | Nutritional supplements | Others |
Atorvastatin Fluvastatin Lovastatin Pitavastatin Pravastatin Rosuvastatin Fenofibrate Bezafibrate Ezetimibe |
ACE inhibitors Angiotensin receptor blockers (ARBs) Calcium channel blockers Thiazide diuretics Adrenergic receptor antagonists (alpha and beta blockers) Vasodilators Renin inhibitors |
Vitamin D, E, K and multivitamins Niacin Omega 3 and fatty acids Anti-oxidants Calcium Co-enzyme Q10 Selenium Folic acid Garlic |
Fixed dose combinations ‘polypill’ Antiplatelet agent (Aspirin) |
Lifestyle-modification interventions | |||
Dietary interventions | Health promotion | Exercise/physical activity in general | |
Mediterranean diet Fibres Nut consumption Chocolate Fruits and vegetables Green and black tea Reduced salt intake Reduced fat intake |
Smoking cessation Weight reduction Reduction in alcohol intake Multiple risk factors intervention Digital health promotion |
Endurance (or aerobic) exercise Strengthening exercise Balance Tai-chi Flexibility Yoga Aquatic Qiqong Transcendental meditation Combined exercise |
|
Structural and policy-based interventions (population-wide interventions) | |||
Taxation and subsidies Mass media campaigns Food and menu labelling Local food environment Worksite wellness programmes Marketing restrictions Quality standards Healthy local environment Addressing air pollution |